【Cheng Yeh Medical】Company announces that its important subsidiary, Xing Ye Biotechnology Co., Ltd., has signed a syndicated loan agreement with a banking consortium
Cheng Yeh Medical's important subsidiary, Xing Ye Biotechnology Co., Ltd., has signed a syndicated loan agreement for NT$5.3 billion with a consortium of banks, including First Commercial Bank. This agreement aims to replenish working capital and is valid for seven years from the first drawdown date.
📋 Article Processing Timeline
- 📰 Published: May 8, 2026 at 09:00
- 🔍 Collected: May 9, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 9, 2026 at 09:19 (1h 19m after Collected)
1. Date of occurrence of the event: 115/05/08
2. Counterparty to the contract or commitment: First Commercial Bank, Taipei Fubon Commercial Bank, and other 6 syndicated loan banking consortiums.
3. Relationship with the company: None
4. Start and end dates of the contract or commitment (or termination date): 7 years from the first drawdown date.
5. Main content (not applicable to termination): Syndicated loan agreement for NT$5.3 billion.
6. Restrictive clauses (not applicable to termination): Handled in accordance with the syndicated loan agreement.
7. Commitments (not applicable to termination): Handled in accordance with the syndicated loan agreement.
8. Other important agreed matters (not applicable to termination): Handled in accordance with the syndicated loan agreement.
9. Impact on the company's finance and business: Replenishment of working capital
10. Specific purpose: Replenishment of working capital
11. Other matters that need to be specified (If the subject of the event or resolution is a public company or above, this material information also meets the requirements of Article 7, Paragraph 8 of the Enforcement Rules of the Securities and Exchange Act regarding matters that have a significant impact on shareholders' equity or securities prices): None
Keyword: Material Information
2. Counterparty to the contract or commitment: First Commercial Bank, Taipei Fubon Commercial Bank, and other 6 syndicated loan banking consortiums.
3. Relationship with the company: None
4. Start and end dates of the contract or commitment (or termination date): 7 years from the first drawdown date.
5. Main content (not applicable to termination): Syndicated loan agreement for NT$5.3 billion.
6. Restrictive clauses (not applicable to termination): Handled in accordance with the syndicated loan agreement.
7. Commitments (not applicable to termination): Handled in accordance with the syndicated loan agreement.
8. Other important agreed matters (not applicable to termination): Handled in accordance with the syndicated loan agreement.
9. Impact on the company's finance and business: Replenishment of working capital
10. Specific purpose: Replenishment of working capital
11. Other matters that need to be specified (If the subject of the event or resolution is a public company or above, this material information also meets the requirements of Article 7, Paragraph 8 of the Enforcement Rules of the Securities and Exchange Act regarding matters that have a significant impact on shareholders' equity or securities prices): None
Keyword: Material Information